Northcape Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Northcape Wealth Management's LLY Position: Q1 2026 in Review
Northcape Wealth Management reduced its Eli Lilly (LLY) stake by 3.6% in Q1 2026, selling an estimated $174K and leaving 4,656 shares worth $4.28M. The position accounts for 1.17% of the portfolio, ranked #26.
Northcape Wealth Management first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $6.49M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Northcape Wealth Management held 4,656 shares of Eli Lilly worth $4.28M as of Q1 2026.
- Northcape Wealth Management sold 172 Eli Lilly shares in Q1 2026, an estimated $174K.
- Eli Lilly made up 1.17% of Northcape Wealth Management's portfolio in Q1 2026, its #26 holding.
- Northcape Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
- Northcape Wealth Management's Eli Lilly position peaked at $6.49M in Q2 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.